Outlook Therapeutics - Russ Trenary, President & CEO

Outlook Therapeutics | C. Russell Trenary III - President & CEOПодробнее

Outlook Therapeutics - Russ Trenary, President & CEOПодробнее

Outlook Therapeutics - Russell Trenary, President & CEOПодробнее

Outlook Therapeutics submits BLA to FDA for its investigational therapy to treat wet AMDПодробнее

Age-Related Macular Degeneration and Diabetes-Related Eye Diseases Series ft. Outlook TherapeuticsПодробнее

Outlook Therapeutics reaches another milestone with FDA acceptance of wet AMD applicationПодробнее